Catalent Inc - ESG Rating & Company Profile powered by AI
Full ESG assessment of Catalent Inc can be accessed by registering for free. The page contains a Q&A table on Catalent Inc. The assessment of Catalent Inc employs intelligence from across the web as well as from available documents by Catalent Inc.
Catalent Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 3.5; made up of an environmental score of 3.0, social score of 4.0 and governance score of 3.4.
3.5
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1144 | Veerhealth Care Ltd | 3.6 | Medium |
| 1144 | iStreet Network Ltd | 3.6 | Medium |
| 1186 | Catalent Inc | 3.5 | Medium |
| 1186 | CRISPR Therapeutics AG | 3.5 | Medium |
| 1186 | Akero Therapeutics Inc | 3.5 | Medium |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Catalent Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Catalent Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Catalent Inc report the average age of the workforce?
Sign up for free to unlockDoes Catalent Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Catalent Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Catalent Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Catalent Inc offer flexible work?
Sign up for free to unlockDoes Catalent Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Catalent Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Catalent Inc conduct supply chain audits?
Sign up for free to unlockDoes Catalent Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Catalent Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Catalent Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Catalent Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Catalent Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Catalent Inc disclose water use targets?
Sign up for free to unlockDoes Catalent Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Catalent Inc have a product recall in the last two years?
Sign up for free to unlockDoes Catalent Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Catalent Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Catalent Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Catalent Inc disclose parental leave metrics?
Sign up for free to unlockDoes Catalent Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Catalent Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Catalent Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Catalent Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Catalent Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Catalent Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Catalent Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Catalent Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Catalent Inc disclose its waste policy?
Sign up for free to unlockDoes Catalent Inc report according to TCFD requirements?
Sign up for free to unlockDoes Catalent Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Catalent Inc disclose energy use targets?
Sign up for free to unlockDoes Catalent Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Catalent Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Catalent Inc
These potential risks are based on the size, segment and geographies of the company.
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products, such as prescription drugs, over-the-counter medications, dietary supplements, unit-dose cosmetics, and animal health medicinal preparations. The Biologics segment provides biologic cell-line; develops and manufactures cell therapy and viral based gene therapy; formulation, development, and manufacturing for parenteral dose forms, including vials, prefilled syringes, vials, and cartridges; and analytical development and testing services. The Oral and Specialty Delivery segment offers formulation, development, and manufacturing across a range of technologies along with integrated downstream clinical development and commercial supply solutions. This segment also offers oral delivery solutions platform comprising pre-clinical screening, formulation, analytical development, and current good manufacturing practices services. The Clinical Supply Services segment offers manufacturing, packaging, storage, distribution, and inventory management for drugs and biologics, and cell and gene therapies in clinical trials. The company also offers FlexDirect direct-to-patient and FastChain demand-led clinical supply services. It serves pharmaceutical, biotechnology, and consumer health companies; and companies in other healthcare market segments, such as animal health and medical devices, as well as in cosmetics industries. The company was incorporated in 2007 and is headquartered in Somerset, New Jersey.